Aman M. G. et al. (2017)
Journal of Child and Adolescent Psychopharmacology
June, 27(5), pp. 403-412.
Fung L. K. et al. (2014)
Journal of Autism and Developmental Disorders
November, 44(11), pp. 2971-2977.
Gengoux G. W. et al. (2015)
Pivotal response treatment parent training for autism: Findings from a 3-month follow-up evaluation.
Journal of Autism and Developmental Disorders
September, 45(9), pp. 2889-2898.
Handen B. L. , Sahl R. , Hardan A. Y. (2008)
Guanfacine in children with autism and/or intellectual disabilities.
Journal of Developmental and Behavioral Pediatrics
29(4), pp. 303-308
Handen B. L. et al. (2011)
Journal of Child and Adolescent Psychopharmacology
February, 21(1), pp. 43-50
Hardan A. Y. et al. (2012)
A randomized controlled pilot trial of oral N-acetylcysteine in children with autism.
Biological Psychiatry
71(11), pp. 956-961.
Hardan A. Y. , Handen B. L. (2002)
Journal of Child and Adolescent Psychopharmacology
12(3), pp. 237-24
Hardan A. Y. , Jou R. , Handen B. L. (2005)
Retrospective study of quetiapine in children and adolescents with pervasive developmental disorders
Journal of Autism and Developmental Disorders
35 pp. 387-391
Jou R. , Handen B. L. , Hardan A. Y. (2005)
Journal of Child and Adolescent Psychopharmacology
15(2), pp. 325-330
Minjarez M. B. et al. (2011)
Pivotal response group treatment program for parents of children with autism.
Journal of Autism and Developmental Disorders
41(1), pp. 92-101.
Showing 1 to 18 of 18 Results